3 results
Primary Objective: The primary objective for this study is to compare the efficacy of ABP 215 with bevacizumab.Secondary Objective(s): The secondary objectives are to assess the safety and immunogenicity of ABP 215 compared with bevacizumab.
To determine the (cost)effectiveness of OTHER (Occupational Therapy at Home E-Rehabilitation), as compared to usual OT, on improving the self-perceived performance in daily activities of community-dwelling older persons post-stroke over a 24-week…
The primary objective is to compare the efficacy of daratumumab when combined with lenalidomide and dexamethasone (DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival (PFS) in subjects with relapsed or…